Roth Capital Starts BioMarin (BMRN) at Hold; $27 PT
Tweet Send to a Friend
Roth Capital initiates coverage on BioMarin Pharmaceutical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
